Beautycounter Founder Returns As CEO; Inter Parfum’s FY2023 Results; Cosmetics News

Gregg Renfrew will start as CEO at the company she founded on 1 February. Separately, International Flavors & Fragrances taps J. Erik Fyrwald to succeed Frank Clyburn as CEO, Inter Parfums reports fiscal 2023 full-year results, Yellow Wood Partners acquires Chapstick, and more.

Woman announcing
• Source: Shutterstock

Beautycounter founder Gregg Renfrew will return to the company as CEO after selling the business in 2021 to the Carlyle Group, announces Counter Brands, LLC, a division of the private equity firm. In a 19 January release, the Santa Monica-based firm notes Renfrew, who will replace interim CEO and board director Mindy Mackenzie, will assume the role on 1 February. Counter Brands reported it was seeking a permanent replacement last summer. (Also see "L’Oreal Bets On Biotech; Beautycounter Launches CEO Search; NIVEA ‘Skin Out Loud’; Cosmetics News" - HBW Insight, 7 June, 2023.)

“We are thrilled to welcome back Gregg to lead Beautycounter in this important next phase of growth. Gregg, as the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Leadership

People On The Move: Appointments At Opella, Stada, Futura

 
• By 

Latest European appointments: Opella names Germany director; Stada has new Western Europe head; Futura makes CEO change.

Kris Joshi Named Norstella CEO, Prioritizes AI Innovation

 
• By 

Joshi joins the parent company of Citeline, home of HBW Insight, to focus on AI, business harmonization and long-term growth.

Over The Counter: How To Balance Access And Equity In Self-Care, With Bayer’s Emese Csoke

HBW Insight speaks to Bayer Consumer Health's global strategy director for regulatory, medical, safety, quality, and compliance Emese Csoke about how least how widening access to self-care solutions can be balanced with equity with regards to affordability.

Kennedy Appears Ill-Informed On Major Pharma Priorities, Creating Unique Lobbying Dynamics

 

Health and Human Services secretary made incorrect statements about the status of key industry priorities at a recent House hearing, which actually may be a good thing for drug sponsors.

More from HBW Insight

US FDA Extracts More Evidence To Ban Kratom

 

Recent warning letters to seven companies marketing products with kratom extract known as 7-OH are FDA’s first in three years referencing unlawful products containing kratom and the first of all its kratom-related warnings to reference extracts from the botanical.

House OMUFA Reauthorization Bill Takes On Clarifying Standards For Tests To Meet GRASE

 

Health Subcommittee will discuss reauthorizing OMUFA during a hearing on how to “maintain and improve” the public health workforce and rural health as well as access to OTC medicines.

Beauty Market Uncertainty Stalls Large M&A, But Middle-Market Deals Continue – Capstone

 

Middle-market beauty deals, which are defined as those with targets of $10m to $100m worth of enterprise value, are driving transaction momentum year-to-date that is in-line with levels during the same period last year, according to Capstone Partners’ Consumer Investment Banking Group.